However, the dichotomy in HHLA2 expression between tumor cells and TAMs highlights the complexity of its role in tumor progression and immune modulation, with one study observing that HHLA2 expression in TAMs was correlated with poorer prognosis in PC (Zhu et al. 2022). This evidence concerns the gene HHLA2 and pachyonychia congenita.